IELSG39

IELSG39International prospective phase 2 trial addressing the efficacy of first-line Chlamydophila psittaci-eradicating therapy with protracted administration of doxycycline followed by eradication monitoring and antibiotic re-treatment at infection re-occurrence in patients with newly diagnosed Ocular Adnexal Marginal Zone Lymphoma (OAMZL)
Participants required:44 (enrolment completed)
Investigator responsible(s):A. Ferreri, E. Zucca, S. Govi
Objective(s):To establish in a prospective, multicentre phase 2 trial, the efficacy of an upfront targeted therapy consisting of Cp-eradicating therapy with prolonged administration of doxycycline followed by eradication monitoring and antibiotic re-treatment at infection re-occurrence in patients with newly diagnosed OAMZL.

Home | Go to Studies

Top